Treeline Biosciences Overview
- Founded
-
2021
- Status
-
Private
- Employees
-
128
- Latest Deal Type
-
Series A1
- Latest Deal Amount
-
$261M
- Investors
-
10
Treeline Biosciences General Information
Description
Developer of transformative precision medicines intended to treat cancer and other serious conditions. The company's drug discovery platform includes mechanistic biology, medicinal chemistry, computational science, structural biology, and protein science, enabling medical professionals to cure cancer.
Contact Information
Website
www.treeline.bio
Formerly Known As
JHB Explorations
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
- 677 Washington Boulevard
- Suite 525
- Stamford, CT 06901
- United States
Treeline Biosciences Timeline
Treeline Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC (Series A1) | 11-Oct-2022 | $261M | 00000 | 00.000 | Completed | Startup |
| 1. Early Stage VC (Series A) | 09-Apr-2021 | 00000 | 00000 | 00000 | Completed | Startup |
Treeline Biosciences Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-1 | 00,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 00.000 | |
| Series A | 00,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Treeline Biosciences Executive Team (5)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Jeffrey Engelman Ph.D | Co-Founder & Chief Scientific Officer & Board Member | ||
| Brian Sara | Director, Human Resources | ||
| Michelle Buturla | Senior Director of Finance & Accounting | ||
| Teresa Lavoie | Senior Vice President, Legal | ||
| Joshua Bilenker MD | Co-Founder & Chief Executive Officer & Board Member |
Treeline Biosciences Board Members (7)
| Name | Representing | Role | Since |
|---|---|---|---|
| Aftab Kherani | Treeline Biosciences | Board Member | 000 0000 |
| Ali Satvat | Self | Board Member | 000 0000 |
| Avi Naider | Self | Board Member | 000 0000 |
| David Bonita | Self | Board Member | 000 0000 |
| David Schenkein | Treeline Biosciences | Board Member | 000 0000 |
Treeline Biosciences Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Treeline Biosciences Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Access Industries | Corporation | Minority | 000 0000 | 000000 0 | |
| Aisling Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Ajax Health | PE-Backed Company | Minority | 000 0000 | 000000 0 | |
| ARCH Venture Partners | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Casdin Capital | Hedge Fund | Minority | 000 0000 | 000000 0 |